Atlas Trials

A Phase Ib Study of the Recombinant Mycobacterium Tuberculosis Vaccine Freeze-dried (AEC/BC02)

Clinical trial NCT04239313 · COMPLETED

Trial details

NCT number
NCT04239313
Sponsor
Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Tuberculosis
Start date
2020-05-27
Primary completion
2021-02-24
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.